About Aril Bioscience Private Limited
Data last updated:
Aril Bioscience Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2018PTC304667. Its GSTIN is 27AAQCA4809E1ZL (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Hiral Piyush Botadra and Piyush Hiralal Botadra.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 808 F.P.No. 765 Tps 111 Jn. Off S V Road Boriwali West, Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.52 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹42.17 Lakh (net margin 1.2%) and EBITDA of ₹56.52 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 32% over five years.
For more details, the company can be reached via its website arilpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address808 F.P.No. 765 Tps 111 Jn. Off S V Road Boriwali West, Mumbai, Maharashtra, India – 400092
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aril Bioscience Private Limited
The main business activity of Aril Bioscience is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aril Bioscience Private Limited FY 2025 filings available
Aril Bioscience Private Limited reported revenue of ₹34.52 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aril Bioscience Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 36% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aril Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹56.52 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹42.17 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aril Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aril Bioscience are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aril Bioscience Private Limited
Aril Bioscience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wiscon Pharmaceuticals Private Limited | ₹34.98 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Kumar Brothers Pharma Private Limited | ₹34.94 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Akshaya Scientifics Private Limited | ₹34.78 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Secunderabad, Telangana, India |
| Raghavam Logistics Private Limited | ₹34.67 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Raipur, Chattisgarh, India |
| Medsol India Overseas Private Limited | ₹34.67 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Noida, Uttar Pradesh, India |
| Aril Bioscience Private Limited this company | ₹34.52 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Mumbai, Maharashtra, India |
| Drug Centre Delhi Private Limited | ₹34.44 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Delhi, India |
| Adinarayan Associates Private Limited | ₹34.35 Cr (FY 2024) | •••• | •••• | 201.0% | •••• | Cuttack, Orissa, India |
| Warner (India) Pharma Private Limited | ₹34.07 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
| Materia Meditech Private Limited | ₹34.07 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Delhi, India |
| Ashok GNXT Pharma Private Limited | ₹34.06 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Aril Bioscience by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aril Bioscience Private Limited
Aril Bioscience Private Limited is audited by HEMAL RAMESH SHAH & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HEMAL RAMESH SHAH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aril Bioscience Private Limited
Aril Bioscience has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hiral Piyush Botadra | Director | 25 Jan 2018 | 8 Years 8 Months | Current |
| Piyush Hiralal Botadra Also directs: Aptive Pharma Private Limited | Director | 25 Jan 2018 | 8 Years 8 Months | Current |
Ownership and Shareholding of Aril Bioscience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aril Bioscience Private Limited
Aril Bioscience Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aril Bioscience Private Limited
Employment history and EPFO contributions of people linked to Aril Bioscience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aril Bioscience Private Limited
Aril Bioscience Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Hiral Piyush Botadra was appointed as Director on 25 Jan 2018.
Credit Ratings, Litigation & Regulatory Alerts for Aril Bioscience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aril Bioscience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aril Bioscience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aril Bioscience Private Limited
Aril Bioscience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAQCA4809E1ZL | Maharashtra | Active | 12 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aril Bioscience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aril Bioscience Private Limited
Aril Bioscience is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 January 2018 (8+ years old) and is registered under CIN U24304MH2018PTC304667.
Aril Bioscience reported revenue of ₹34.52 Cr for FY 2025 (up 36% YoY).
Aril Bioscience has 2 current directors:
- Hiral Piyush Botadra - Director
- Piyush Hiralal Botadra - Director
Aril Bioscience reported a net profit of ₹42.17 Lakh (net margin 1.2%) and EBITDA of ₹56.52 Lakh (EBITDA margin 1.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aril Bioscience is 8% over three years and 32% over five years. In the latest year (FY 2025) revenue rose 36%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aril Bioscience is 27AAQCA4809E1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aril Bioscience is U24304MH2018PTC304667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aril Bioscience was incorporated on 25 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aril Bioscience by revenue are Wiscon Pharmaceuticals Private Limited, Kumar Brothers Pharma Private Limited, Akshaya Scientifics Private Limited, Raghavam Logistics Private Limited, Medsol India Overseas Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Hiral Piyush Botadra was appointed as Director on 25 Jan 2018. Piyush Hiralal Botadra was appointed as Director on 25 Jan 2018.
Aril Bioscience can be reached through the website arilpharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.